SK Boston Consulting Group Matrix

SK On, the electric vehicle battery division of SK Innovation, is projecting a significant business turnaround in North America during the latter half of 2025. This optimistic outlook is fueled by the anticipated double-digit sales growth, largely attributed to the ramp-up of new production facilities within the United States and the financial advantages offered by the US Advanced Manufacturing Production Tax Credits. These credits are designed to incentivize domestic battery production, directly benefiting SK On's expansion strategy.

Despite encountering financial losses in its nascent stages, the electric vehicle battery sector continues to represent a robust high-growth market. SK On's ambitious capacity expansion plans, coupled with its strategic concentration on key geographical markets like North America, firmly position it as a potential Star within the competitive landscape. The company's commitment to scaling production aligns with the increasing global demand for electric vehicles.

SK Hynix's dominance in the HBM market, supplying key AI chipmakers, positions it as a clear Star. Its Q1 2025 global DRAM market share surpassing Samsung, driven by HBM demand, underscores this Star status.

SK Telecom's aggressive AI infrastructure expansion, including AIDC and AIX, with plans for an 'AI Infrastructure Superhighway,' signifies its Star potential. This strategic pivot aims to capture substantial future AI revenue.

SK On's projected North American turnaround in late 2025, fueled by US production ramp-ups and tax credits, marks it as a Star. Despite initial losses, the EV battery sector's high growth and SK On's capacity expansion are key indicators.

SK Ecoplant's engagement in the green hydrogen market, including a large Egypt project targeting 2029 commercial operation, highlights its Star potential. Developing a full green hydrogen value chain reinforces this positioning.

SK Bioscience's advanced vaccine pipeline, particularly its next-generation pneumococcal vaccine in Phase III trials and mRNA platform development, firmly establishes it as a Star. These efforts target high-growth vaccine segments with significant unmet needs.

SK Geo Centric, a key player within SK Innovation, operates firmly in the petrochemical sector. This industry, while mature, represents a significant portion of SK Group's revenue, generating consistent cash flow.

As an established entity, SK Geo Centric commands a substantial market share across a range of chemical products. In 2023, SK Innovation's overall petrochemical segment reported strong performance, contributing significantly to the group's financial stability.

The steady and substantial cash generated by SK Geo Centric's petrochemical operations is crucial. It provides the necessary capital to fuel SK Group's strategic investments in high-growth, emerging sectors like advanced materials and renewable energy, ensuring a balanced growth strategy.

Cash cows in the SK Group, like SK Telecom's mobile services, represent established businesses with strong market positions that generate consistent, high cash flow. These segments, while experiencing low growth, require minimal investment, allowing them to fund other ventures within the group. For example, SK Telecom's mobile business, with over 31 million subscribers in 2023, consistently delivers stable revenue, with ARPU around 25,000 KRW in Q1 2024.

SK Energy's refining operations and SK Broadband's broadband/IPTV services also function as cash cows. SK Energy achieved operating profits of approximately 2.5 trillion KRW in 2023, showcasing its profitability in a mature sector. SK Broadband, in turn, posted a record operating profit of 268.4 billion KRW in 2023, demonstrating the financial strength of its core services.

SK Enmove's lubricant business is another prime example, consistently generating substantial profits and cash flow in its mature market. These cash cows are vital for SK Group, providing the financial backbone to support investments in emerging and high-growth areas.

Within SK Group's chemical operations, such as those managed by SK Chemical or SK Geo Centric, certain legacy or commoditized chemical products might be facing significant challenges. These products often operate in mature, highly competitive global markets where differentiation is minimal, leading to low market share and stagnant growth. For instance, some basic petrochemicals or plastics may fall into this category, experiencing pricing pressure from larger international players.

These less competitive segments typically yield low profit margins and can become cash traps, demanding continuous capital for maintenance and operations without substantial returns. An example could be older grades of polyethylene or polypropylene where global capacity has outstripped demand, forcing producers to compete primarily on price. SK Group needs to regularly evaluate these product lines to decide on potential divestment or strategic restructuring to free up resources for more promising ventures.

By 2024, the global chemical industry continues to see consolidation and a push towards specialty chemicals. Companies like SK are increasingly focusing on high-value, sustainable materials. For example, SK Chemical has been investing heavily in bio-based plastics and advanced materials, signaling a strategic shift away from less competitive traditional products. This trend suggests that older, undifferentiated chemical lines will likely see reduced investment and increased scrutiny for their long-term viability within the group's portfolio.

Businesses categorized as Dogs in the SK BCG Matrix represent ventures with low market share and low growth potential. These are often mature businesses facing declining demand or intense competition, requiring careful management to avoid becoming cash drains.

SK Square's investment in 11th Street exemplifies a business struggling to gain significant market traction, often categorized as a Dog due to its persistent operational challenges and inability to achieve profitability. Such ventures tie up capital without generating substantial returns.

SK Inc. C&C's older IT services, lacking AI integration, are likely positioned as Dogs. These traditional offerings face shrinking demand as the market shifts towards innovative, intelligent solutions, impacting their market share and growth prospects.

In the chemical sector, commoditized products with limited differentiation and facing price pressure from global competitors can fall into the Dog category. These segments often yield low profit margins and require continuous capital for maintenance.

SK Bioscience is making significant strides in developing its mRNA vaccine platform, exemplified by its Japanese encephalitis vaccine progressing into global clinical trials. This positions them in a high-growth area of vaccine technology.

While mRNA represents a promising future, SK Bioscience is a newer player compared to established leaders in this specific domain. This necessitates substantial research and development investment to carve out a competitive market position.

Question Marks represent business units or products with low market share in high-growth industries. These ventures require significant investment to increase market share and can potentially become Stars if successful, or Dogs if they fail to gain traction.

SK E&S's hydrogen initiatives, SK Telecom's 'A dot' AI agent, SK Bioscience's mRNA vaccine development, SK Ecoplant's CCUS technology, and SK Square's Web3 investments all fit this profile. They are in rapidly expanding markets but currently hold minimal market share.

The success of these Question Marks hinges on substantial capital allocation for research, development, and market penetration. For example, the global CCUS market is projected to grow significantly, but SK Ecoplant needs to invest heavily to capture a piece of it.

SK Square's investment in Korbit, a cryptocurrency exchange, exemplifies the high-risk, high-reward nature of these Question Mark ventures in the volatile digital asset market.